Brent Kendrick
Brent Kendrick is founder and owner of First Principles Biopharma, LLC, specializing in biopharmaceutical data sciences, data analysis automation, and consulting in formulation/analytical development/product characterization.
Michael Jewett
Michael Jewett is the Charles Deering McCormick Professor of Teaching Excellence, the Walter P. Murphy Professor of Chemical and Biological Engineering, and Director of the Center for Synthetic Biology at Northwestern University. Dr. Jewett received his PhD in 2005 at Stanford University, completed postdoctoral studies at the Center for Microbial Biotechnology in Denmark and the Harvard Medical School, and was a guest professor at the Swiss Federal Institute of Technology (ETH Zurich). He is the recipient of the NIH Pathway to Independence Award, David and Lucile Packard Fellowship in Science and Engineering, Camille-Dreyfus Teacher-Scholar Award, and a Finalist for the Blavatnik National Awards for Young Scientists, among others. He is the co-founder of SwiftScale Biologics, Stemloop, Inc., Pearl Bio, Induro Therapeutics, and Design Pharmaceuticals. Jewett is a Fellow of AIMBE, AAAS, and NAI.
Bazarragchaa Damdinsuren
Bazarragchaa Damdinsuren, MD, PhD is a product quality team leader at Office of Biotechnology Products (OBP), Office of Pharmaceutical Quality at CDER, FDA. Dr. Damdinsuren received his MD from National Medical University in Mongolia and his PhD from Osaka University in Japan, and completed postdoc in immunology and cell biology at the National Institutes of Health (NIH). He joined the OBP/FDA as a Commissioner’s Fellow in 2010.
Dr. Seongkyu Yoon is a Professor in the Department of Chemical Engineering and the Ward Endowed Professor in Biomedical Sciences at UMass Lowell. He is also the UMass Site Director of the Advanced Mammalian Biomanufacturing Innovation Center and a contributor to the National Biomanufacturing Innovation Institute. Dr. Yoon runs a systems biology group that conducts research on systems biotechnology, life science informatics, bioprocess data analytics, and regulatory sciences with the objective of developing innovative biomanufacturing platforms for protein/cell/gene biotherapeutics.
Richard D. Braatz
Participating Instructor
Dr. Richard D. Braatz is the Edwin R. Gilliland Professor of Chemical Engineering at MIT, where he conducts research into advanced biopharmaceutical manufacturing systems. In this role, he leads process data analytics, mechanistic modeling, and control systems for several projects on campus, including those focused on monoclonal antibody, viral vaccine, and gene therapy manufacturing.
Get more from your bioprocess data. In this intensive, four-day course, designed specifically for scientists and engineers in the biopharma industry, you’ll explore best practices for translating biopharmaceutical manufacturing data into reliable models and better decisions. Working with academic and industry experts, you’ll acquire strategies for improving manufacturing accuracy, enhancing regulatory efficiency, and refining bioprocess operations.
Derrick Katayama
Derrick Katayama, Ph.D. is the Principal Scientist at Legacy BioDesign, LLC. Dr. Katayama received his Ph.D. in Pharmaceutical Sciences from the University of Colorado Health Sciences Center (UCHSC) with studies focused on understanding protein stability in both liquid and lyophilized forms. Dr. Katayama has worked in the biopharmaceutical industry for over 10 years, prior to joining Legacy BioDesign, LLC.
Explore the latest strategies for stabilizing biotherapeutics, with a focus on solving mechanisms of instability. Designed for scientists and engineers working in biopharmaceutical discovery, development, and manufacturing, this dynamic four-day course explores various strategies for overcoming challenges related to the stability, solubility, and viscosity of biotherapeutics. There is a focus on a fundamental mechanistic understanding of protein stability, providing the basis for formulating and stabilizing biopharmaceuticals. The course will also present advances in emerging areas, such as cell and gene therapy as well as machine learning.
Delve into the latest in biological and biochemical technology, with an emphasis on biological systems with industrial practices. The longest-running course in the MIT Professional Education catalog, this popular program reviews fundamentals and provides an up-to-date account of current industry knowledge. Alongside accomplished peers, you’ll acquire the tools you need to improve existing biological manufacturing systems or design new ones for downstream processes.
Explore the innovative biotechnology strategies that are improving processes in biological industries around the world. Over the course of five days, you’ll acquire the tools and frameworks you need to enhance your organization’s downstream process—and drive increased value. Through highly interactive lectures and activities, you’ll examine traditional unit operations, as well as new concepts and emerging technologies, which offer benefits to biochemical product recovery.